CD4 and neoplasm: The cDC1 subset excel at cross‐presentation of exogenous microbial and tumour antigens to efficiently prime CD8+ T cells and activate CD4+ T cells through MHC class II antigen (MHCII) presentation resulting in the polarization of activated CD4+ T cells towards a Th1 phenotype [18, 19, 20, 21].